Table 1 Clinical trials for intestinal ischemia reperfusion injury
Do not mix separate-vial peptides in one syringe they have different stability and pH requirements
Figure 9 Several pre-clinical studies illustrated the indirect interactions between gut microbiota and radiation injuries, especially brain injuries via the MGBA
Descarga la app, Escucha
For any synthetic AT developed, it is important to know which biomolecule the agent is designed to protect, by which mechanism (scavenging RS, preventing RS formation, increasing endogenous defense mechanisms, and/or supporting oxidative damage repair), whether it can generate RS, and if there are any adverse effects associated with RS suppression
THNH PHN: Water, Dipropylene Glycol, Caprylic/Capric Triglyceride, Niacinamide, Cetyl Ethylhexanoate, 1,2-Hexanediol, Squalane, Dimethicone, Glutathione, Cetearyl Olivate, Polysorbate 20, Phenoxyethanol, Sorbitan Olivate, Cetearyl Alcohol, Triethanolamine, Carbomer, Tocopheryl Acetate, Adenosine, Glycerin, Butylene Glycol, C13-14 Isoparaffin, Xanthan Gum, Disodium EDTA, Oryza Sativa (Rice) Bran Extract, Milk Protein Extract, Punica Granatum Fruit Extract, Cornus Officinalis Fruit Extract, Rosa Damascena Flower Extract, Pulsatilla Koreana Extract, Hippophae Rhamnoides Fruit Extract, Rosa Canina Fruit Extract, Zanthoxylum Piperitum Fruit Extract, Usnea Barbata (Lichen) Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Laureth-7, Centella Asiatica Extract, Glyceryl Acrylate/Acrylic Acid Copolymer, Fragrance, Ethylhexylglycerin, Kojyl Carboxy Dipeptide-23, Caprylyl Glycol
